Cannabis is a group of flowering plants that has been long used for industrial, recreational and medical purposes. When relating to its medical use, the terms "Medical Cannabis" or "Medical marijuana" has become prevalent. In this course we will use the term "Medical Cannabis". Nowadays, Medical Cannabis involves multiple medical disciplines such as neuroscience, pain, pharmacology, oncology, psychiatry and more. Moreover, it has cultural, agricultural and social, legal and political implications. This course will give you a solid ground to understand the whole picture. By completing this course, you will gain a broad understanding and knowledge base related to medical use of cannabis for pain control. You will be exposed to a wide range of topics such as historical use of cannabis in ancient times, botanic aspects of the plants, and potential benefits and risks associated with its medical use to both individuals and society.
Cannabis and headache
Loading...
Do curso por Technion - Israel Institute of Technology
Medical Cannabis for Pain Control
20 classificações
Explore Related Videos
At Coursera, you will find the best lectures in the world. Here are some of our personalized recommendations for you
Na lição
Effectiveness for pain
Conheça os instrutores
Elon EisenbergProfessor of Neurology and Pain Medicine
Institute of Pain Medicine, Rambam Health Care Campus
Headaches are common among adults but very
considerably in their presentation and in their underlying causes.
The International Headache Society introduced a formal classification of headaches
a few years ago to simplify diagnoses and accuracy of treatment.
Without getting into too much detail,
we can categorize headache into two classes: primary and secondary.
I'll start with secondary headaches.
These headaches are a symptom of a more serious medical condition.
They represent an identifiable underlying pathology such as meningitis,
an infectious disease of the membranes surrounding the brain,
stroke, brain tumor, sinusitis, and so forth.
Primary headaches are those which are not symptoms of other illnesses.
They are the illness.
Common examples are tension headache and migraine headaches.
Less common are cluster headaches,
which are recurrent severe headaches on one side of the head and stabbing headaches,
experienced after eating ice cream, for example.
Today, in the context of medical cannabis,
I will stick to discussion of chronic forms of primary headaches.
By chronic primary headaches,
I'm not referring to those experienced occasionally
by most healthy people after a sleepless night,
insufficient hydration, or at the end of particularly hot or stressful day.
Since these headaches appear only occasionally and
tend to disappear without any specific treatment,
we don't discard them here.
Chronic primary headaches tend to be much more complicated and present
a therapeutic challenge to both patients and caregivers.
The two principle goals when treating headaches are to reduce the frequency, severity,
and duration of headache attacks by means of
prevention and to abort an existing headache.
So, in the case of migraine,
a drug will be prescribed for use on a daily basis for prevention,
whereas an abortive therapy such as an anti-inflammatory drug, a triptan,
or another available anti-migraine drug will be
prescribed when a headache occurs and preferably as it starts.
Now, let's review the literature on medical cannabis
while paying attention to the different types of headaches,
which we're already familiar with and to
the potentially preventive and abortive qualities of medical cannabis.
There are many good reasons to believe that medical cannabis
can be effective for various types of headaches.
Unfortunately, much like in the case of acute pain,
no more than a dozen reports can be found in
the medical literature on the effectiveness of medical cannabis for headaches,
and these are merely anecdotal or based on small cohorts of patients at most.
Following our few examples,
three surveys of marijuana smokers in
Europe and in the United States show that between five percent
and 10 percent of users employed
medical cannabis for relief of migraine and other headaches,
but it is unclear from these surveys if marijuana was used preventively or abortively.
Two French surveys of patients with cluster headaches found that
somewhere between a quarter and a half of these patients
consume marijuana for their headaches.
According to one of these surveys,
a clear analgesic effect was reported in only a quarter of these users.
A recent American survey of 124 migraine patients,
to whom medical cannabis was prescribed,
found reduction in headache frequency in nearly 20 percent of the patients and
abortive effect leading to termination of headache attack
was found in an additional 12 percent.
The remaining reports are based on
much smaller groups of patients and on single-case reports.
In one such study on three patients,
smoked medical cannabis relieved chronic headaches similar
to or better than other abortive medications,
such as aspirin or ergotamine.
In another small survey of three patients,
migraine attack appeared following cessation of daily marijuana smoking.
In one of these patients,
remission of headache was reported in response to resuming marijuana use.
In two other case reports,
one patient with persistent migraine and another with
persistent cluster headache responded well to smoked marijuana.
An Italian RCT from 2013
studied the effect of the synthetic cannabinoid medication, nabilone,
against a very familiar anti-inflammatory drug,
ibuprofen, in patients with medication overuse headache.
But here, two points deserve consideration.
First, nabilone is licensed in several countries mainly for chemotherapy,
induced nausea, and vomiting and for wasting
syndrome caused by AIDS but not as a pain medication.
Second, medication overuse headache is one of the most difficult headache to treat.
Many patients who suffer this condition have
dealt with tension or migraine headache for many years.
They gradually increase the dose of headache medication,
reaching a point where they consume
very large quantities of analgesics with no real pain relief.
Putting an end to pain killers is challenging for many of these patients,
and they require a supervised detox program,
somewhat similar to the treatment of narcotic drug addictions.
In the Italian study,
30 such patients were randomly divided into two groups.
One group received nabilone for eight weeks and following a two-week drug free interval,
received ibuprofen for an additional eight weeks.
The second group received the same drugs but in a reverse order.
The measured outcome included reduction in frequency, duration,
and intensity of headache pain,
as well as reduction in daily consumption of analgesics.
Additional parameters include a change in anxiety,
depression, drug dependence, and quality of life.
Researchers analyzed the results of 26 patients who completed the study,
and, as anticipated, found improvement in many outcomes measures in both groups.
I say as anticipated because in almost all pain trials,
we observe an improvement in measured outcomes just from participation in the study.
In the Italian study,
nabilone was superior to ibuprofen in reducing the frequency and intensity of headaches.
Furthermore, nabilone reduce the level of
medication dependence and improve quality of life,
whereas ibuprofen did not.
Why the results of the study are encouraging,
it is difficult to draw broad conclusions due to the small number of patients,
limited duration of follow-up,
only two weeks after the end of treatment and the fact that nabilone
is not equivalent to smoked herbal cannabis.
Lastly, a few words on the secondary headaches.
Do you recall what we said about secondary headaches?
They are symptoms of other conditions, and interestingly,
certain types of secondary headaches also seem to respond to medical cannabis.
For example, the pressure inside the skull may sometimes increase.
This condition is known as increased intracranial pressure and is
commonly accompanied by headaches and additional neurological signs and symptoms.
Medical cannabis appears to lower increased intracranial pressure and,
in so doing, modifies the associated headaches.
More on secondary headaches later in our course.
Explore nosso catálogo
Registre-se gratuitamente e obtenha recomendações, atualizações e ofertas personalizadas.
O Coursera proporciona acesso universal à melhor educação do mundo fazendo parcerias com as melhores universidades e organizações para oferecer cursos on-line.
© 2019 Coursera Inc. Todos os direitos reservados.
